Jensen J, Lundgren J. Novel biomarkers of infection in critically ill cancer patients: certainties and doubts*. Crit Care Med. 2014;42:2632-3 pubmed publisher

Debiane L, Hachem R, Al Wohoush I, Shomali W, Bahu R, Jiang Y, et al. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med. 2014;42:2500-7 pubmed publisher

Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, et al. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial. Am J Emerg Med. 2014;32:334-41 pubmed publisher

Wang L, Gala M, Yamamoto M, Pino M, Kikuchi H, Shue D, et al. Adrenomedullin is a therapeutic target in colorectal cancer. Int J Cancer. 2014;134:2041-50 pubmed publisher

Zhou Y, Sun H, Chen D, Liu T, Han Y, Wang J, et al. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats. Hypertension. 2014;63:330-7 pubmed publisher

De Giorgio A, Castellano L, Krell J, Stebbing J. Crosstalk-induced loss of miR-126 promotes angiogenesis. Oncogene. 2014;33:3634-5 pubmed publisher

Chang J, Duan X, Zhang B, Teng X, Zhou Y, Liu Y, et al. Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway. Exp Biol Med (Maywood). 2013;238:1136-46 pubmed publisher

Letourneau M, Nguyen Q, Harel F, Fournier A, Dupuis J. PulmoBind, an adrenomedullin-based molecular lung imaging tool. J Nucl Med. 2013;54:1789-96 pubmed publisher

Liu K, Deng X, Gong L, Chen X, Wang S, Chen H, et al. The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat. Clin Lab. 2013;59:589-96 pubmed

Li P, Sun H, Han Y, Wang J, Zhang F, Tang C, et al. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats. Peptides. 2013;47:1-6 pubmed publisher

Kirisci M, Oktar G, Ozogul C, Oyar E, Akyol S, Demirtaş C, et al. Effects of adrenomedullin and vascular endothelial growth factor on ischemia/reperfusion injury in skeletal muscle in rats. J Surg Res. 2013;185:56-63 pubmed publisher

Green L, Cookson A, Bruce I, Donn R, Ray D. Identification of multiple, oxygen-stable HIF1 alpha isoforms, and augmented expression of adrenomedullin in rheumatoid arthritis. Clin Exp Rheumatol. 2013;31:672-82 pubmed

Li M, Schwerbrock N, Lenhart P, Fritz Six K, Kadmiel M, Christine K, et al. Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta. J Clin Invest. 2013;123:2408-20 pubmed publisher

Kach J, Sandbo N, Sethakorn N, Williams J, Reed E, La J, et al. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin. Am J Physiol Lung Cell Mol Physiol. 2013;304:L757-64 pubmed publisher

Park S, Kim J, Son T, Yi J, Kim N, Yang K, et al. The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia. Biochem Biophys Res Commun. 2013;434:722-7 pubmed publisher

Fedorowski A, Burri P, Struck J, Juul Moller S, Melander O. Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort. J Intern Med. 2013;273:359-67 pubmed publisher

Martínez Herrero S, Martinez A. Cancer protection elicited by a single nucleotide polymorphism close to the adrenomedullin gene. J Clin Endocrinol Metab. 2013;98:E807-10 pubmed publisher

Schuetz P, Litke A, Albrich W, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26:159-67 pubmed publisher

Smith J, Halse K, Damm P, Lindegaard M, Amer Wahlin I, Hertel S, et al. Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes. Biomark Med. 2013;7:139-46 pubmed publisher

Eliasson L. New drug for treatment of insulin-resistant complication?. Acta Physiol (Oxf). 2013;207:432-3 pubmed publisher

Verweij N, Mahmud H, Mateo Leach I, de Boer R, Brouwers F, Yu H, et al. Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1. Hypertension. 2013;61:602-8 pubmed publisher

Nikitenko L, Shimosawa T, Henderson S, Makinen T, Shimosawa H, Qureshi U, et al. Adrenomedullin haploinsufficiency predisposes to secondary lymphedema. J Invest Dermatol. 2013;133:1768-76 pubmed publisher

Fei X, Hongxiang Z, Qi C, Daozhen C. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia. Adv Clin Exp Med. 2012;21:573-9 pubmed

Koyama T, Ochoa Callejero L, Sakurai T, Kamiyoshi A, Ichikawa Shindo Y, Iinuma N, et al. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation. 2013;127:842-53 pubmed publisher

Yoshizawa T, Sakurai T, Kamiyoshi A, Ichikawa Shindo Y, Kawate H, Iesato Y, et al. Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system. Hypertension. 2013;61:341-51 pubmed publisher

Al Shuaibi M, Bahu R, Chaftari A, Al Wohoush I, Shomali W, Jiang Y, et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013;56:943-50 pubmed publisher

Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno N, Yamamoto M. Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol Gastrointest Liver Physiol. 2013;304:G428-36 pubmed publisher

Alehagen U, Dahlstrom U, Rehfeld J, Goetze J. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure. J Card Fail. 2013;19:31-9 pubmed publisher

Dai X, Ma W, He X, Jha R. Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma. Med Oncol. 2013;30:347 pubmed publisher

Jehn M, Schindler C, Meyer A, Tamm M, Koehler F, Witt C, et al. Associations of daily walking activity with biomarkers related to cardiac distress in patients with chronic obstructive pulmonary disease. Respiration. 2013;85:195-202 pubmed publisher

Crisafulli E, Mannino D. Do we now have a 'couch potato' blood test?. Respiration. 2013;85:193-4 pubmed publisher

Wong B, Lam K, Lee C, Wong V, Lam M, Chu I, et al. Adrenomedullin enhances invasion of human extravillous cytotrophoblast-derived cell lines by regulation of urokinase plasminogen activator expression and s-nitrosylation. Biol Reprod. 2013;88:34 pubmed publisher

Garcia Honduvilla N, Cifuentes A, Bellon J, Bujan J, Martinez A. The angiogenesis promoter, proadrenomedullin N-terminal 20 peptide (PAMP), improves healing in both normoxic and ischemic wounds either alone or in combination with autologous stem/progenitor cells. Histol Histopathol. 2013;28:115-25 pubmed publisher

Suzuki Y, Itoh H, Katagiri F, Sato F, Sato Y, Kawasaki K, et al. Development and clinical application of an enzyme immunoassay for the determination of midregional proadrenomedullin. J Pept Sci. 2013;19:59-63 pubmed publisher

Tzikas S, Keller T, Ojeda F, Zeller T, Wild P, Lubos E, et al. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain. Heart. 2013;99:388-95 pubmed publisher

Yang X, Zhang H, Jia Y, Ni L, Li G, Xue L, et al. Effects of intermedin1-53 on myocardial fibrosis. Acta Biochim Biophys Sin (Shanghai). 2013;45:141-8 pubmed publisher